Why the study?
Does a drug-coated balloon-only strategy improve long-term clinical outcomes in patients with de novo lesions of large coronary arteries?
Does a drug-coated balloon-only strategy improve long-term clinical outcomes in patients with de novo lesions of large coronary arteries?
A drug-coated balloon-only strategy appears safe and effective for treating de novo lesions in large coronary arteries, though randomized trials are needed to confirm these findings.
Answers are grounded in this paper and cite their sources.
May support DCB-only use in large de novo lesions; leaves open randomized confirmation of outcomes.
DCB-only strategy for de novo lesions in large coronary arteries appears to be safe and effective for both bifurcation and non-bifurcation lesions. Further randomized clinical trials are warranted to confirm the value of DCB-only strategy in de novo bifurcation lesions of large vessels.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: